Ideal for GP practices, asthma clinics and NHS respiratory services, this portable FeNO monitor is simple to use and provides reliable readings in under 12 seconds. The NObreath® V2 helps guide corticosteroid treatment, reduce overprescribing, and support asthma control reviews in line with NICE and BTS/SIGN recommendations.
Key Features
Measures FeNO in adults and children in as little as 10–12 seconds
Full-colour touchscreen display with clear on-screen prompts
Traffic light colour coding for instant interpretation
Built-in ambient NO test mode
USB connectivity for exporting results to patient records
Lightweight, antimicrobial casing for routine clinical use
The Bedfont NObreath® V2 is widely used in primary care settings as a trusted solution for asthma diagnosis. It offers clinicians a reliable way to assess airway inflammation levels, track patient response to treatment, and tailor inhaled corticosteroid prescriptions more effectively. It’s also ideal for FeNO monitoring during routine asthma reviews and for patients with suspected steroid-resistant asthma.
Clinical Use and Compliance
The NObreath® V2 is fully compliant with NICE Diagnostic Guidance NG245, making it suitable for FeNO testing in GP surgeries, NHS community asthma services, and private practice. It also supports treatment pathways outlined by the British Thoracic Society (BTS) and SIGN asthma guidelines.
Support and Training
We offer full training and support to help your team implement FeNO testing effectively. Whether you're introducing this for QOF-aligned asthma reviews or upgrading existing asthma monitoring equipment, our team is here to assist.
Need Accessories?
Browse our range of Bedfont NObreath® mouthpieces and approved accessories to support effective FeNO testing in clinical settings.
This is usually a stock item - Please allow 1 to 3 working days delivery
In most cases, items in stock that are ordered before 12 noon are delivered on a next working day service.
If you need this item urgently please use the live chat or call us to enquire about our premium rate delivery service including same-day, timed and weekend deliveries. For more information about delivery, please visit our delivery information page here
1. What does the Bedfont NObreath® V2 FeNO Monitor do?
The NObreath® V2 FeNO Monitor measures fractional exhaled nitric oxide (FeNO) levels in the breath. FeNO is a recognised biomarker of airway inflammation, helping clinicians assess and monitor asthma in both adults and children. It is a quick, non-invasive method for guiding treatment with inhaled corticosteroids.
2. How is FeNO testing used in asthma diagnosis?
FeNO testing is recommended by NICE; as a valuable tool in confirming asthma where diagnosis is uncertain. The NObreath® V2 helps identify patients with eosinophilic airway inflammation, allowing for more accurate diagnosis and tailored asthma treatment plans in line with BTS/SIGN guidelines.
3. Is the NObreath® V2 suitable for use in GP surgeries?
Yes. The device is designed for primary care use, including GP practices, asthma clinics, and community health teams. It supports NHS asthma review frameworks, helps improve QOF outcomes, and integrates easily into routine reviews and new patient assessments.
4. How long does a FeNO test take using the NObreath® V2?
A full FeNO test takes around 12 seconds for adults and 10 seconds for children. The results are displayed immediately via a colour-coded traffic light system on the device’s touchscreen, making it easy to interpret.
5. What does a high FeNO level mean?
Elevated FeNO levels typically indicate ongoing airway inflammation, often due to poorly controlled or untreated asthma. The NObreath® V2 helps clinicians decide whether to start, adjust, or step down inhaled corticosteroid therapy based on objective data.
6. Does the NObreath® V2 need calibration?
Yes. The device is serviced and calibrated by the manufacturer at recommended intervals. Calibration is not performed manually. For servicing information, please contact our support team or refer to the Bedfont service guide.
7. Can the NObreath® be used for children?
Absolutely. The monitor supports FeNO testing in children aged 5 years and over. It’s quick, safe, and suitable for use during routine asthma reviews or initial diagnosis.
8. Is the device compliant with UK asthma guidelines?
Yes. The NObreath® V2 is compliant with NICE NG245 guidance and supports asthma pathways outlined in the BTS/SIGN national guidelines. It is widely used across NHS and private respiratory care settings.
9. What accessories are available for the NObreath® V2?
We supply Bedfont-approved mouthpieces and accessories to support safe and effective FeNO testing. These are designed for single-patient use and ensure accurate, hygienic operation in line with clinical best practice.
10. Does the NObreath® V2 integrate with patient record systems?
Yes. Test results can be exported via USB and added to most clinical systems including EMIS and SystmOne. This ensures FeNO data can be documented and reviewed during routine asthma care and medication reviews.
1420500.jpg 
